1,334
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Design, synthesis, biological evaluation and molecular docking study of novel pleuromutilin derivatives containing substituted benzoxazole as antibacterial agents

, , , , , , & ORCID Icon show all
Article: 2251712 | Received 20 May 2023, Accepted 20 Aug 2023, Published online: 04 Sep 2023

References

  • David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev. 2010;23(3):616–687.
  • Tenover FC, McDougal LK, Goering RV, Killgore G, Projan SJ, Patel JB, Dunman PM. Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J Clin Microbiol. 2006;44(1):108–118.
  • Qin HL, Liu J, Fang WY, Ravindar L, Rakesh KP. Indole-based derivatives as potential antibacterial activity against methicillin-resistance Staphylococcus aureus (MRSA). Eur J Med Chem. 2020;194:112245.
  • Washer P, Joffe H. The "hospital superbug": social representations of MRSA. Soc Sci Med. 2006;63(8):2141–2152.
  • Ippolito G, Leone S, Lauria FN, Nicastri E, Wenzel RP. Methicillin-resistant Staphylococcus aureus: the superbug. Int J Infect Dis. 2010;14(Suppl 4):S7–S11.
  • Huffman BJ, Shenvi RA. Natural products in the "Marketplace": interfacing synthesis and biology. J Am Chem Soc. 2019;141(8):3332–3346.
  • Kavanagh F, Hervey A, Robbins WJ. Antibiotic substances from basidiomycetes: VIII. Pleurotus Multilus (Fr.) Sacc. and pleurotus passeckerianus pilat. Proc Natl Acad Sci USA. 1951;37(9):570–574.
  • Kavanagh F, Hervey A, Robbins WJ. Antibiotic substances from basidiomycetes: IX. Drosophila Subtarata. (Batsch Ex Fr.) Quel. Proc Natl Acad Sci USA. 1952;38(7):555–560.
  • Hogenauer G. The mode of action of pleuromutilin derivatives. Location and properties of the pleuromutilin binding site on Escherichia coli ribosomes. Eur J Biochem. 1975;52(1):93–98.
  • Woodford N, Afzal-Shah M, Warner M, Livermore DM. In vitro activity of retapamulin against Staphylococcus aureus isolates resistant to fusidic acid and mupirocin. J Antimicrob Chemother. 2008;62(4):766–768.
  • van Duijkeren E, Greko C, Pringle M, Baptiste KE, Catry B, Jukes H, Moreno MA, Pomba MCMF, Pyörälä S, Rantala M, et al. Pleuromutilins: use in food-producing animals in the European Union, development of resistance and impact on human and animal health. J Antimicrob Chemother. 2014;69(8):2022–2031.
  • Daum RS, Kar S, Kirkpatrick P. Retapamulin. Nat Rev Drug Discov. 2007;6(11):865–866.
  • Lee YR, Jacobs KL. Leave it to Lefamulin: a pleuromutilin treatment option in community-acquired bacterial pneumonia. Drugs. 2019;79(17):1867–1876.
  • Luo J, Yang QE, Yang YY, Tang YZ, Liu YH. Design, synthesis, and structure-activity relationship studies of novel pleuromutilin derivatives having a piperazine ring. Chem Biol Drug Des. 2016;88(5):699–709.
  • Jin Z, Wang L, Gao H, Zhou YH, Liu YH, Tang YZ. Design, synthesis and biological evaluation of novel pleuromutilin derivatives possessing acetamine phenyl linker. Eur J Med Chem. 2019;181:111594.
  • Wang Q, Liu J, Zhou Z-D, Zhou K-X, Li F, Zhang Q-W, Wang S-K, Wang W, Jin Z, Tang Y-Z, et al. Design, synthesis, biological evaluation and molecular docking studies of novel pleuromutilin derivatives containing nitrogen heterocycle and alkylamine groups. J Enzyme Inhib Med Chem. 2022;37(1):2078–2091.
  • Boschelli DH, Connor DT, Bornemeier DA, Dyer RD, Kennedy JA, Kuipers PJ, Okonkwo GC, Schrier DJ, Wright CD. 1,3,4-Oxadiazole, 1,3,4-thiadiazole, and 1,2,4-triazole analogs of the fenamates: in vitro inhibition of cyclooxygenase and 5-lipoxygenase activities. J Med Chem. 1993;36(13):1802–1810.
  • Kohli P, Srivastava SD, Srivastava SK. Synthesis and biological activity of mercaptobenzoxazole based thiazolidinones and their arylidenes. Jnl Chinese Chemical Soc. 2007;54(4):1003–1010.
  • Refaey SAM, Taha F, Abd El-Malak AM. Inhibition of stainless steel pitting corrosion in acidic medium by 2-mercaptobenzoxazole. Appl Surf Sci. 2004;236(1–4):175–185.
  • Kakkar S, Tahlan S, Lim SM, et al. Benzoxazole derivatives: design, synthesis and biological evaluation. Chem Cent J. 2018;12(1):92.
  • Sattar R, Mukhtar R, Atif M, Hasnain M, Irfan A. Synthetic transformations and biological screening of benzoxazole derivatives: a review. J Heterocycl Chem. 2020;57(5):2079–2107.
  • Dorababu A. Synthesis, pharmacological evaluation and structure-activity relationship of recently discovered enzyme antagonist azoles. Heliyon. 2020;6(4):e03656.
  • Muntoni F, Tejura B, Spinty S, Roper H, Hughes I, Layton G, Davies KE, Harriman S, Tinsley J. A Phase 1b trial to assess the pharmacokinetics of ezutromid in pediatric duchenne muscular dystrophy patients on a balanced diet. Clin Pharmacol Drug Dev. 2019;8(7):922–933.
  • Oehlers L, Mazzitelli CL, Brodbelt JS, Rodriguez M, Kerwin S. Evaluation of complexes of DNA duplexes and novel benzoxazoles or benzimidazoles by electrospray ionization mass spectrometry. J Am Soc Mass Spectrom. 2004;15(11):1593–1603.
  • Li B, Zhang Z, Zhang J-F, Liu J, Zuo X-Y, Chen F, Zhang G-Y, Fang H-Q, Jin Z, Tang Y-Z, et al. Design, synthesis and biological evaluation of pleuromutilin-Schiff base hybrids as potent anti-MRSA agents in vitro and in vivo. Eur J Med Chem. 2021;223:113624.
  • Azizian H, Esmailnejad A, Vavsari VF, Mahernia S, Amanlou M, Balalaie S. Pantoprazole derivatives: synthesis, urease inhibition assay and in silico molecular modeling studies. Chemistry. 2020;5(15):4580–4587.
  • Kavaliauskas P, Grybaite B, Mickevicius V, Petraitiene R, Grigaleviciute R, Planciuniene R, Gialanella P, Pockevicius A, Petraitis V. Synthesis, ADMET properties, and in vitro antimicrobial and antibiofilm activity of 5-Nitro-2-thiophenecarbaldehyde N-((E)-(5-Nitrothienyl)methylidene)hydrazone (KTU-286) against staphylococcus aureus with defined resistance mechanisms. Antibiotics. 2020;9(9):612.
  • Ahmad I, Huang L, Hao H, Sanders P, Yuan Z. Application of PK/PD modeling in veterinary field: dose optimization and drug resistance prediction. Biomed Res Int. 2016;2016:5465678–12.
  • Zhanel GG, Craig WA. Pharmacokinetic contributions to postantibiotic effects. Focus on aminoglycosides. Clin Pharmacokinet. 1994;27(5):377–392.
  • Liu J, Zhang G-Y, Zhang Z, Li B, Chai F, Wang Q, Zhou Z-D, Xu L-L, Wang S-K, Jin Z, et al. Design, synthesis, in vitro and in vivo evaluation against MRSA and molecular docking studies of novel pleuromutilin derivatives bearing 1, 3, 4-oxadiazole linker. Bioorg Chem. 2021;112:104956.
  • MacKenzie FM, Gould IM. The post-antibiotic effect. J Antimicrob Chemother. 1993;32(4):519–537.
  • Jin Z, Yang YZ, Chen JX, Tang YZ. Inhibition of pro-inflammatory mediators in RAW264.7 cells by 7-hydroxyflavone and 7,8-dihydroxyflavone. J Pharm Pharmacol. 2017;69(7):865–874.
  • Trott O, Olson AJ. Software news and update AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455–461.